The peer-reviewed study, entitled “US Cannabis Laws Projected To Cost Generic And Brand Pharmaceutical Firms Billions”, analyzed how publicly traded pharmaceutical firms fared after adult-use or medical marijuana laws were enacted by states. According to Ziemowit Bednarek, California Polytechnic State University’s Finance Department, together with Sarah Stith, pharmaceutical stocks were worth 1.5-2% lower in only 10 days following cannabis legalization.
The new cannabis beverage boom isn’t really about replacing booze. It’s about replacing everything people…
Amber Senter co-founded Supernova Women, the organization that helped shape America’s first cannabis social equity…
The finding: states that legalized medical or recreational marijuana saw significant reductions in non-fatal opioid…
Eighty-eight percent. Let that sit for a moment. According to the latest nationwide polling from…
A story that once sounded like peak internet fantasy has taken a very real turn. …
Your June 2026 horoscopes brings a powerful mix of growth, reflection, and fresh opportunities. The…